NCT02343965

Brief Summary

Each year, 17000 cases of severe hematological diseases are diagnosed in France, with more than 6,000 of these requiring hospitalization in a protective, sterile environment. New methods, such as touch massage, have emerged in response to anxiety symptoms observed in patients in such sterile and isolated surroundings. We hypothesize that during the period of isolation, touch massage becomes a nursing care which can help the patient.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
62

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2015

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2015

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

January 12, 2015

Completed
10 days until next milestone

First Posted

Study publicly available on registry

January 22, 2015

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
Last Updated

January 21, 2016

Status Verified

January 1, 2015

Enrollment Period

11 months

First QC Date

January 12, 2015

Last Update Submit

January 20, 2016

Conditions

Keywords

Touch-massageanxietyleukemiahaematologycancerologysupportive carecomplementary therapy

Outcome Measures

Primary Outcomes (1)

  • Impact of touch-massage practice on patients' anxiety state, as measured by the anxiety-state questionnaire (Spielberger, CD et al, 1983) to assess the predisposition to anxiety.

    Each patient will complete the anxiety-state questionnaire (Spielberger, CD et al, 1983) to assess the predisposition to anxiety. The evolution of patient anxiety is calculated from the six scores of the anxiety-state scale administered before and after each of the 3 sessions of touch-massageusing the trait anxiety scale score.

    3 weeks

Secondary Outcomes (3)

  • Evolution of Self Esteem, as measured by the self-esteem questionnaire

    3 weeks

  • Evolution of anxiety, measured by the the anxiety-state questionnaire (Spielberger, CD et al, 1983)

    3 weeks

  • Evolution of anxiety

    3 weeks

Study Arms (2)

Touch-massage group

EXPERIMENTAL

Patient receive 3 sessions of touch-massage (the duration of a session of touch massage is 15 minutes) ,once a week, for 3 weeks

Other: Touch-massage

without touch-massage group

NO INTERVENTION

Interventions

Touch-massage group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with hematologic diseases (leukaemia, Myeloma, lymphoma) hospitalized in a sterile area of a hematology unit for at least 3 weeks
  • to 65 years
  • Female or male
  • Not having met the nurse, who is providing the touch-massage

You may not qualify if:

  • Allergy to sweet almond oil
  • Injury to the skin, at the back and / or arms and / or hands
  • Cognitive impairment and / or preventing psychiatric responses to interviews and / or questionnaires
  • Physical inability to take sitting in an ergonomic chair for the conduct of touch massage.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Simon A, Nizard JJ, Chevalier P, Le Gouill S, Rulleau T, Planche L, Evin A. Impact of the practice of touch-massage(R) by a nurse on the anxiety of patients with hematological disorders hospitalized in a sterile environment, a randomized, controlled study. BMC Complement Med Ther. 2024 Jan 2;24(1):1. doi: 10.1186/s12906-023-04302-3.

MeSH Terms

Conditions

Hematologic DiseasesAnxiety DisordersLeukemia

Condition Hierarchy (Ancestors)

Hemic and Lymphatic DiseasesMental DisordersNeoplasms by Histologic TypeNeoplasms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 12, 2015

First Posted

January 22, 2015

Study Start

January 1, 2015

Primary Completion

December 1, 2015

Study Completion

December 1, 2015

Last Updated

January 21, 2016

Record last verified: 2015-01